MOLECULAR EPIDEMIOLOGY OF HUMAN RETROVIRUSES: HIV IN ASIA & PACIFIC
MOLECULAR EPIDEMIOLOGY OF HUMAN RETROVIRUSES: HIV IN ASIA & PACIFIC
批准号:
6121545
负责人:
Cecilia M. Shikuma
金额:
$33.9万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-09-14 至 1999-08-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
For most of Asia and the Pacific, the acquired immunodeficiency
syndrome (AIDS) had not been identified prior to the late l 980s and
the number of cumulative cases is still quite low (I). However, AIDS
is now a public health emergency in Thailand, and many neighboring
countries are also at high risk of epidemic spread of human
immunodeficiency virus type (HIV-l) infection.For example, studies in
Papua New Guinea (the largest and most populous of the Pacific island
nations) indicate widespread high-risk sexual behaviors and high rates
of sexually transmitted diseases, particularly ulcerative genital
conditions. Vital baseline data are needed on the HIV-1 subtypes
present in Southeast Asia and in countries, like Papua New Guinea,
where health care delivery systems and high rates of syphilis and
tuberculosis are comparable to those in sub-Saharan Africa. Also, the
endemicity of human T-cell lymphotropic virus type I (HTLV-I)
infection in some Melanesian populations in Papua New Guinea places
such groups at added risk for HIV-1 infection because of the
immunosuppressive and T-cell activation properties of HTLV-I.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clinical Research and Regulatory Support Core
-
批准号:10474450
-
项目类别:
-
资助金额:$32.55万
-
财政年份:2021
-
负责人:Cecilia M. Shikuma
-
依托单位:
Clinical Research and Regulatory Support Core
-
批准号:10685401
-
项目类别:
-
资助金额:$32.62万
-
财政年份:2021
-
负责人:Cecilia M. Shikuma
-
依托单位:
Clinical Research and Regulatory Support Core
-
批准号:10281549
-
项目类别:
-
资助金额:$32.28万
-
财政年份:2021
-
负责人:Cecilia M. Shikuma
-
依托单位:
Maraviroc and NeuroAIDS Pathogenesis
-
批准号:8667965
-
项目类别:
-
资助金额:$67.99万
-
财政年份:2014
-
负责人:Cecilia M. Shikuma
-
依托单位:
Maraviroc and NeuroAIDS Pathogenesis
-
批准号:9266148
-
项目类别:
-
资助金额:$3.84万
-
财政年份:2014
-
负责人:Cecilia M. Shikuma
-
依托单位:
Maraviroc and NeuroAIDS Pathogenesis
-
批准号:9096234
-
项目类别:
-
资助金额:$64.5万
-
财政年份:2014
-
负责人:Cecilia M. Shikuma
-
依托单位:
Clinical Studies
-
批准号:8061611
-
项目类别:
-
资助金额:$45.01万
-
财政年份:2010
-
负责人:Cecilia M. Shikuma
-
依托单位:
HIV RESEARCH CORE
-
批准号:7960428
-
项目类别:
-
资助金额:$40.27万
-
财政年份:2009
-
负责人:Cecilia M. Shikuma
-
依托单位:
HIV and Global Drug Therapies: Peripheral Neuropathy Complications and Mechanisms
-
批准号:8112457
-
项目类别:
-
资助金额:$65.97万
-
财政年份:2008
-
负责人:Cecilia M. Shikuma
-
依托单位:
HIV and Global Drug Therapies: Peripheral Neuropathy Complications and Mechanisms
-
批准号:8133664
-
项目类别:
-
资助金额:$3.42万
-
财政年份:2008
-
负责人:Cecilia M. Shikuma
-
依托单位:
Role of Oxidative Stress and Inflammation in HIV Cardiovascular Risk
-
批准号:7691231
-
项目类别:
-
资助金额:$90.86万
-
财政年份:2008
-
负责人:Cecilia M. Shikuma
-
依托单位:
Clinical Studies
-
批准号:7618642
-
项目类别:
-
资助金额:$34.27万
-
财政年份:2008
-
负责人:Cecilia M. Shikuma
-
依托单位:
Role of Oxidative Stress and Inflammation in HIV Cardiovascular Risk
-
批准号:8321529
-
项目类别:
-
资助金额:$89.07万
-
财政年份:2008
-
负责人:Cecilia M. Shikuma
-
依托单位:
Role of Oxidative Stress and Inflammation in HIV Cardiovascular Risk
-
批准号:8112673
-
项目类别:
-
资助金额:$87.4万
-
财政年份:2008
-
负责人:Cecilia M. Shikuma
-
依托单位:
Role of Oxidative Stress and Inflammation in HIV Cardiovascular Risk
-
批准号:7898681
-
项目类别:
-
资助金额:$89.06万
-
财政年份:2008
-
负责人:Cecilia M. Shikuma
-
依托单位:
HIV RESEARCH CORE
-
批准号:7725326
-
项目类别:
-
资助金额:$17.81万
-
财政年份:2008
-
负责人:Cecilia M. Shikuma
-
依托单位:
HIV and Global Drug Therapies: Peripheral Neuropathy Complications and Mechanisms
-
批准号:7554680
-
项目类别:
-
资助金额:$68.98万
-
财政年份:2008
-
负责人:Cecilia M. Shikuma
-
依托单位:
HIV and Global Drug Therapies: Peripheral Neuropathy Complications and Mechanisms
-
批准号:8304307
-
项目类别:
-
资助金额:$64.5万
-
财政年份:2008
-
负责人:Cecilia M. Shikuma
-
依托单位:
HIV and Global Drug Therapies: Peripheral Neuropathy Complications and Mechanisms
-
批准号:7672500
-
项目类别:
-
资助金额:$67.47万
-
财政年份:2008
-
负责人:Cecilia M. Shikuma
-
依托单位:
HIV RESEARCH CORE
-
批准号:7609622
-
项目类别:
-
资助金额:$11.91万
-
财政年份:2007
-
负责人:Cecilia M. Shikuma
-
依托单位:
海外基金